Developing novel blood-based biomarkers for Alzheimer's disease

Heather M. Snyder, Maria C. Carrillo, Francine Grodstein, Kim Henriksen, Andreas Jeromin, Simon Lovestone, Michelle M Mielke, Sid O'Bryant, Manual Sarasa, Magnus Sjøgren, Holly Soares, Jessica Teeling, Eugenia D Trushina, Malcolm Ward, Tim West, Lisa J. Bain, Diana W. Shineman, Michael Weiner, Howard M. Fillit

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Alzheimer's disease is the public health crisis of the 21st century. There is a clear need for a widely available, inexpensive and reliable method to diagnosis Alzheimer's disease in the earliest stages, track disease progression, and accelerate clinical development of new therapeutics. One avenue of research being explored is blood based biomarkers. In April 2012, the Alzheimer's Association and the Alzheimer's Drug Discovery Foundation convened top scientists from around the world to discuss the state of blood based biomarker development. This manuscript summarizes the meeting and the resultant discussion, including potential next steps to move this area of research forward.

Original languageEnglish (US)
Pages (from-to)109-114
Number of pages6
JournalAlzheimer's and Dementia
Volume10
Issue number1
DOIs
StatePublished - Jan 2014

Fingerprint

Alzheimer Disease
Biomarkers
Drug Discovery
Research
Disease Progression
Public Health
Therapeutics

Keywords

  • Alzheimer's disease
  • Biomarker
  • Blood based biomarker
  • Diagnostics
  • Early detection
  • Early diagnosis

ASJC Scopus subject areas

  • Health Policy
  • Epidemiology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience
  • Developmental Neuroscience
  • Clinical Neurology

Cite this

Snyder, H. M., Carrillo, M. C., Grodstein, F., Henriksen, K., Jeromin, A., Lovestone, S., ... Fillit, H. M. (2014). Developing novel blood-based biomarkers for Alzheimer's disease. Alzheimer's and Dementia, 10(1), 109-114. https://doi.org/10.1016/j.jalz.2013.10.007

Developing novel blood-based biomarkers for Alzheimer's disease. / Snyder, Heather M.; Carrillo, Maria C.; Grodstein, Francine; Henriksen, Kim; Jeromin, Andreas; Lovestone, Simon; Mielke, Michelle M; O'Bryant, Sid; Sarasa, Manual; Sjøgren, Magnus; Soares, Holly; Teeling, Jessica; Trushina, Eugenia D; Ward, Malcolm; West, Tim; Bain, Lisa J.; Shineman, Diana W.; Weiner, Michael; Fillit, Howard M.

In: Alzheimer's and Dementia, Vol. 10, No. 1, 01.2014, p. 109-114.

Research output: Contribution to journalArticle

Snyder, HM, Carrillo, MC, Grodstein, F, Henriksen, K, Jeromin, A, Lovestone, S, Mielke, MM, O'Bryant, S, Sarasa, M, Sjøgren, M, Soares, H, Teeling, J, Trushina, ED, Ward, M, West, T, Bain, LJ, Shineman, DW, Weiner, M & Fillit, HM 2014, 'Developing novel blood-based biomarkers for Alzheimer's disease', Alzheimer's and Dementia, vol. 10, no. 1, pp. 109-114. https://doi.org/10.1016/j.jalz.2013.10.007
Snyder HM, Carrillo MC, Grodstein F, Henriksen K, Jeromin A, Lovestone S et al. Developing novel blood-based biomarkers for Alzheimer's disease. Alzheimer's and Dementia. 2014 Jan;10(1):109-114. https://doi.org/10.1016/j.jalz.2013.10.007
Snyder, Heather M. ; Carrillo, Maria C. ; Grodstein, Francine ; Henriksen, Kim ; Jeromin, Andreas ; Lovestone, Simon ; Mielke, Michelle M ; O'Bryant, Sid ; Sarasa, Manual ; Sjøgren, Magnus ; Soares, Holly ; Teeling, Jessica ; Trushina, Eugenia D ; Ward, Malcolm ; West, Tim ; Bain, Lisa J. ; Shineman, Diana W. ; Weiner, Michael ; Fillit, Howard M. / Developing novel blood-based biomarkers for Alzheimer's disease. In: Alzheimer's and Dementia. 2014 ; Vol. 10, No. 1. pp. 109-114.
@article{6b3b4009e88f4c88bb48d7ff561d6d9f,
title = "Developing novel blood-based biomarkers for Alzheimer's disease",
abstract = "Alzheimer's disease is the public health crisis of the 21st century. There is a clear need for a widely available, inexpensive and reliable method to diagnosis Alzheimer's disease in the earliest stages, track disease progression, and accelerate clinical development of new therapeutics. One avenue of research being explored is blood based biomarkers. In April 2012, the Alzheimer's Association and the Alzheimer's Drug Discovery Foundation convened top scientists from around the world to discuss the state of blood based biomarker development. This manuscript summarizes the meeting and the resultant discussion, including potential next steps to move this area of research forward.",
keywords = "Alzheimer's disease, Biomarker, Blood based biomarker, Diagnostics, Early detection, Early diagnosis",
author = "Snyder, {Heather M.} and Carrillo, {Maria C.} and Francine Grodstein and Kim Henriksen and Andreas Jeromin and Simon Lovestone and Mielke, {Michelle M} and Sid O'Bryant and Manual Sarasa and Magnus Sj{\o}gren and Holly Soares and Jessica Teeling and Trushina, {Eugenia D} and Malcolm Ward and Tim West and Bain, {Lisa J.} and Shineman, {Diana W.} and Michael Weiner and Fillit, {Howard M.}",
year = "2014",
month = "1",
doi = "10.1016/j.jalz.2013.10.007",
language = "English (US)",
volume = "10",
pages = "109--114",
journal = "Alzheimer's and Dementia",
issn = "1552-5260",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Developing novel blood-based biomarkers for Alzheimer's disease

AU - Snyder, Heather M.

AU - Carrillo, Maria C.

AU - Grodstein, Francine

AU - Henriksen, Kim

AU - Jeromin, Andreas

AU - Lovestone, Simon

AU - Mielke, Michelle M

AU - O'Bryant, Sid

AU - Sarasa, Manual

AU - Sjøgren, Magnus

AU - Soares, Holly

AU - Teeling, Jessica

AU - Trushina, Eugenia D

AU - Ward, Malcolm

AU - West, Tim

AU - Bain, Lisa J.

AU - Shineman, Diana W.

AU - Weiner, Michael

AU - Fillit, Howard M.

PY - 2014/1

Y1 - 2014/1

N2 - Alzheimer's disease is the public health crisis of the 21st century. There is a clear need for a widely available, inexpensive and reliable method to diagnosis Alzheimer's disease in the earliest stages, track disease progression, and accelerate clinical development of new therapeutics. One avenue of research being explored is blood based biomarkers. In April 2012, the Alzheimer's Association and the Alzheimer's Drug Discovery Foundation convened top scientists from around the world to discuss the state of blood based biomarker development. This manuscript summarizes the meeting and the resultant discussion, including potential next steps to move this area of research forward.

AB - Alzheimer's disease is the public health crisis of the 21st century. There is a clear need for a widely available, inexpensive and reliable method to diagnosis Alzheimer's disease in the earliest stages, track disease progression, and accelerate clinical development of new therapeutics. One avenue of research being explored is blood based biomarkers. In April 2012, the Alzheimer's Association and the Alzheimer's Drug Discovery Foundation convened top scientists from around the world to discuss the state of blood based biomarker development. This manuscript summarizes the meeting and the resultant discussion, including potential next steps to move this area of research forward.

KW - Alzheimer's disease

KW - Biomarker

KW - Blood based biomarker

KW - Diagnostics

KW - Early detection

KW - Early diagnosis

UR - http://www.scopus.com/inward/record.url?scp=84891073424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891073424&partnerID=8YFLogxK

U2 - 10.1016/j.jalz.2013.10.007

DO - 10.1016/j.jalz.2013.10.007

M3 - Article

C2 - 24365657

AN - SCOPUS:84891073424

VL - 10

SP - 109

EP - 114

JO - Alzheimer's and Dementia

JF - Alzheimer's and Dementia

SN - 1552-5260

IS - 1

ER -